Staff attitudes toward patient care and treatment-disposition behavior.

1969 ◽  
Vol 74 (1) ◽  
pp. 90-94 ◽  
Author(s):  
Alan S. DeWolfe ◽  
Robert P. Barrell ◽  
Fred E. Spaner
1990 ◽  
Vol 2 (2) ◽  
pp. 89-94
Author(s):  
Wendy Levinson ◽  
Karen Kaufman ◽  
Patrick M. Dunn

2019 ◽  
Vol 68 ◽  
pp. 158
Author(s):  
D. Kostova-Lefterova ◽  
K. Genova ◽  
A. Kaneva ◽  
S. Lazarov ◽  
D. Dobrev

2015 ◽  
Vol 10 (01) ◽  
pp. 73 ◽  
Author(s):  
Francesco Muntoni ◽  
Annemieke Aartsma-Rus ◽  
Eugenio Mercuri ◽  
Hanns Lochmüller ◽  
◽  
...  

Duchenne muscular dystrophy (DMD) is a rare X-linked recessive disorder that occurs in around one in 5,000 male births. The prevalence of DMD is expected to rise due to improved standards of care and implementation of guidelines, leading to longer survival. Specialist genetic confirmation of a DMD diagnosis is typically followed by access to specialist care and treatment: the exact DMD-causing mutation should be identified because it can influence prognosis and identify patients eligible for treatment. Since the majority of patients has a deletion or duplication of one or more exons (~70 %), generally multiplex ligation-dependent probe amplification suffices to identify the mutation. Exon sequencing is performed to pick up small mutations (~30 %). Greater awareness of DMD is needed among healthcare professionals to enable earlier diagnosis, which would facilitate family planning, as well as patient care and treatment. In DMD patients who are still able to walk, the 6-minute walk test (6MWT) has been shown to be a valid measure of physical functioning and a predictor of disease progression, with high inter-test reliability. In a study of the natural history of DMD, change in 6MWT of around 30 metres has been indicated to be clinically relevant and clinically meaningful. DMD patients responded to treatment as shown by the improvement in the 6MWT score in the large multinational trial of the nonsense mutation readthrough agent, ataluren (Translarna™) 40 mg/kg/day, where treatment was associated with a 31.3 metres improvement on the 6MWT distance, after 48 weeks, compared with placebo. The Translational Research in Europe–Assessment & Treatment of Neuromuscular Diseases (TREAT-NMD) network was launched to provide an infrastructure to accelerate research and therapy development, increasing collaboration, improving patient care and helping to support ‘clinical trial readiness’. As such, the TREAT-NMD registry network is well placed to support further understanding of DMD and the impact of therapies that may be used over the long term, permitting a host of research questions to be explored.


2013 ◽  
Vol 19 (2) ◽  
pp. 108-114
Author(s):  
Clare Oakley ◽  
Philip Sugarman

SummaryThis article sets out an approach to service improvement and development that depends on psychiatrists acquiring management skills, working with managers and selecting, understanding and using some structured business tools. These are essential elements in the development of clinical leadership and service vision and can add enormously to the improvement of patient care and treatment outcomes. It is important for psychiatrists to begin to acquire these skills during their training and to continue to develop them throughout their careers.


2015 ◽  
Vol 28 (2) ◽  
pp. 135-148 ◽  
Author(s):  
Kerstin Nilsson ◽  
Mette Sandoff

Purpose – The purpose of this study is to gain better understanding of the roles and functions of process managers by describing Swedish process managers’ experiences of leading processes involving patient care and treatment when working in a hierarchical health-care organization. Design/methodology/approach – This study is based on an explorative design. The data were gathered from interviews with 12 process managers at three Swedish hospitals. These data underwent qualitative and interpretative analysis with a modified editing style. Findings – The process managers’ experiences of leading processes in a hierarchical health-care organization are described under three themes: having or not having a mandate, exposure to conflict situations and leading process development. The results indicate a need for clarity regarding process manager’s responsibility and work content, which need to be communicated to all managers and staff involved in the patient care and treatment process, irrespective of department. There also needs to be an emphasis on realistic expectations and orientation of the goals that are an intrinsic part of the task of being a process manager. Research limitations/implications – Generalizations from the results of the qualitative interview studies are limited, but a deeper understanding of the phenomenon was reached, which, in turn, can be transferred to similar settings. Originality/value – This study contributes qualitative descriptions of leading care and treatment processes in a functional, hierarchical health-care organization from process managers’ experiences, a subject that has not been investigated earlier.


2016 ◽  
pp. 29-30
Author(s):  
William L. Nyhan ◽  
Georg F. Hoffmann

2021 ◽  
Vol 21 (1) ◽  
pp. 37-43
Author(s):  
Gerald D. Coleman ◽  

On July 14, 2020, the Congregation for the Doctrine of the Faith (CDF) issued Samaritanus bonus (The Good Samaritan), beckoning the human family to take the Good Samaritan as the ideal in the care of all persons in critical and terminal phases of their lives. The import of this letter is understood best as seen through three prisms: (1) Fratelli tutti, the encyclical of Pope Francis signed at Assisi on October 3, 2020; (2) the Declaration on Euthanasia issued by the CDF in 1980; and (3) “the remarkable progressive development of biomedical technologies [which] has exponentially enlarged the clinical proficiency of diagnostic medicine in patient care and treatment [which] call for growth in moral discernment to avoid an unbalanced and dehumanizing use of the technologies especially in the critical or terminal stages of human life” (CDF, Declaration on Euthanasia, intro)


Author(s):  
Louise O’Keefe ◽  
Faye Anderson

On-site, workplace clinics are one method to control today's healthcare costs. These clinics provide preventive care and treatment to employees at their place of employment, thus increasing their attendance at work. On-site clinics are particularly beneficial for decreasing the number of off-site, health-related, patient care visits. In this article, the authors describe an on-site clinic developed on a university campus. They review the history of on-site clinics, discuss the value of these clinics, present a case study describing the development of an on-site, university-campus clinic that has had a positive financial impact. They conclude that an on-site clinic can be a positive strategy to reduce healthcare costs for both the employer and the employees while promoting the health of the employees.


Sign in / Sign up

Export Citation Format

Share Document